Matinas Biopharma Holdings (MTNB) Earnings Date & Reports

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

MTNB is expected to report earnings to rise 25.00% to -2 cents per share on November 06

Matinas Biopharma Holdings MTNB Stock Earnings Reports

Q3'24

Est.

$-0.03

Q2'24

Beat

by $0.01

Q1'24

Est.

$-0.03

Q4'23

Beat

by $0.01

Q3'23

Est.

$-0.03

The last earnings report on August 14 showed earnings per share of -1 cents, beating the estimate of -2 cents. With 12.37K shares outstanding, the current market capitalization sits at 2.80M.

View a ticker or compare two or three

Compare

MTNB